Metrics as of 10/16/2026, 08:47 AM (Berlin time), refresh in progress.
RUA Life Sciences Stock
RUA Life Sciences plc
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United Kingdom
- CEO
- William Donald Brown
- Employees
- 59
- Market cap
- £18 M
- IPO
- 26/02/1997
RUA Life Sciences plc, operating with its subsidiaries, delivers specialized polymers, various services, and finished products to the global medical device sector, spanning Europe, the United States, and other international markets. The company's operations encompass serving as a contract partner for the development…
RUA Life Sciences stock: price history
1D
-1.7%
1W
+0.0%
1M
+0.0%
6M
+58.3%
YTD
+103.6%
1Y
+147.8%
2Y
+93.2%
5Y
-82.5%
10Y
+12.4%
Next earnings date
Next earnings date
25/01/2027 (in 100 days)
Volatility around earnings
~43% stronger price swings than usual
Ask the agents about RUA Life Sciences
RUA Life Sciences stock metrics
P/E
-123.91
P/B
2.48
EV/EBITDA
-41.19
RETURN ON EQUITY
6.8%
NET MARGIN
25.9%
DEBT/EQUITY
0.19
DIVIDEND YIELD
0.0%
AS OF
30/09/2025
Free float & liquidity
FREE FLOAT
81.2%
FLOAT SHARES
50,418,386
AVG. DAILY VOLUME (30D)
157,969
Dividends & Stock splits
Comparable stocks
Frequently asked questions about RUA Life Sciences stock
What does RUA Life Sciences do?
RUA Life Sciences plc is a company in the Healthcare sector, Medical - Devices industry, headquartered in United Kingdom.
The CEO is William Donald Brown, the company employs around 59 people.
The IPO was on 26/02/1997; the stock trades on LSE under the ticker RUA.L.
When does RUA Life Sciences report next?
The next earnings date is 25/01/2027.
Around past earnings, price swings were roughly 43% stronger than usual.
Does RUA Life Sciences pay a dividend?
No, RUA Life Sciences currently does not pay a dividend.
Which stocks are comparable to RUA Life Sciences?
Comparable stocks include Smith & Nephew, LivaNova, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and Siemens Healthineers.
How can I get RUA Life Sciences stock analyzed?
Clicking "Analyze stock" lets five strategies assess RUA Life Sciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.